Valuation: GSK plc

Market Cap 77.84B 104B 91.34B 84.6B 147B 9,967B 150B 1,008B 395B 4,895B 391B 383B 16,904B P/E 2026 *
12.4x
P/E 2027 * 11.4x
Enterprise Value 93.13B 125B 109B 101B 176B 11,925B 180B 1,206B 473B 5,856B 468B 458B 20,224B EV / Sales 2026 *
2.75x
EV / Sales 2027 * 2.53x
Free-Float
92.29%
Yield 2026 *
3.55%
Yield 2027 * 3.74%
1 day-0.41%
1 week-1.89%
Current month-1.51%
1 month+2.02%
3 months-8.88%
6 months+6.85%
Current year+8.48%
1 week 22.69
Extreme 22.69
23.38
1 month 22
Extreme 22
23.7
Current year 20.27
Extreme 20.27
26.02
1 year 15.35
Extreme 15.35
26.02
3 years 14.68
Extreme 14.675
26.02
5 years 14.62
Extreme 14.62
27.13
10 years 14.62
Extreme 14.62
27.52
Manager TitleAgeSince
Chief Executive Officer - 01/01/2026
Director of Finance/CFO 64 01/05/2023
Chief Tech/Sci/R&D Officer - 01/12/2021
Director TitleAgeSince
Director/Board Member - 06/05/2026
Director/Board Member 64 01/01/2018
Chairman 68 01/09/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.35%-1.89% - - 105B
+0.08%-0.85%+48.85%+173.71% 1,060B
+0.66%-0.12%+65.17%+63.10% 619B
-0.14%-2.59%+29.57%+85.76% 438B
-1.75%-0.33%+28.33%+23.58% 333B
+0.24%-0.42%+29.19%+47.26% 282B
-1.75%-10.57%+18.27%+22.07% 267B
+0.67%+1.03%-26.81%-37.96% 218B
-0.73%-1.51%+21.51%+58.53% 196B
+1.23%+1.35%+17.20%+71.25% 161B
Average -0.13%-3.33%+25.70%+56.37% 397.1B
Weighted average by Cap. -0.06%-3.10%+36.02%+84.64%

Financials

2026 *2027 *
Net sales 33.88B 45.33B 39.76B 36.83B 64.09B 4,339B 65.34B 439B 172B 2,131B 170B 167B 7,358B 35.63B 47.66B 41.8B 38.72B 67.39B 4,562B 68.7B 461B 181B 2,240B 179B 175B 7,737B
Net income 6.52B 8.73B 7.65B 7.09B 12.34B 835B 12.58B 84.49B 33.14B 410B 32.77B 32.05B 1,417B 7.04B 9.42B 8.27B 7.66B 13.32B 902B 13.58B 91.25B 35.79B 443B 35.39B 34.62B 1,530B
Net Debt 15.29B 20.45B 17.94B 16.61B 28.91B 1,957B 29.48B 198B 77.66B 961B 76.8B 75.12B 3,320B 12.22B 16.35B 14.34B 13.28B 23.12B 1,565B 23.57B 158B 62.1B 769B 61.41B 60.07B 2,655B
Logo GSK plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
66,841
Date Price Change Volume
14/07/26 EUR 22.69 -1.05% 232
10/07/26 EUR 22.93 +0.84% 250
09/07/26 EUR 22.74 -0.61% 525
08/07/26 EUR 22.88 -1.34% 220
07/07/26 EUR 23.19 -0.13% 237
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
19.62GBP
Average target price
21.20GBP
Spread / Average Target
+8.08%

Quarterly revenue - Rate of surprise